Comparison of the ABI 7700 System (TaqMan) and Competitive PCR for Quantification of IS6110 DNA in Sputum during Treatment of Tuberculosis

ABSTRACT Mycobacterium tuberculosis can persist in sputum for long periods of time after the initiation of antituberculosis chemotherapy. The purpose of this study was to determine whether quantitative estimates of M. tuberculosis DNA in sputum correlate with the numbers of viable bacilli and thus measure the therapeutic response of patients during treatment. Two methods of M. tuberculosis DNA quantification were examined by using DNA isolated from sputum specimens serially collected during the course of chemotherapy. A competitive PCR assay was compared to an automated system of real-time quantification with the ABI Prism 7700 Sequence Detection System (TaqMan). The ABI 7700 system uses standard PCR in conjunction with a fluorogenic probe in which the intensity of fluorescence is proportional to the amount of target DNA present. The results showed that both PCR systems are reproducible and accurate. The amounts of M. tuberculosis DNA quantified in sputum corresponded well with the numbers of acid-fast bacilli (AFB) counted by microscopy. Before initiation of antituberculosis therapy, measures of AFB, M. tuberculosis DNA, and cultivable bacilli were similar, suggesting that quantification of DNA is a good method for measuring the initial bacillary load. However, the rate of disappearance of both AFB and M. tuberculosis DNA did not correlate with the decline in cultivable bacilli in the specimen; therefore, these tests are not appropriate for monitoring treatment efficacy.

[1]  K. Yuen,et al.  Use of PCR in routine diagnosis of treated and untreated pulmonary tuberculosis. , 1993, Journal of clinical pathology.

[2]  P. Gangadharam.  The Role of the Laboratory in the Management of Tuberculosis Patients , 1981 .

[3]  J. Mannhalter,et al.  Technical aspects of quantitative competitive PCR. , 1996, BioTechniques.

[4]  M. Perkins,et al.  Alkaline decontamination of sputum specimens adversely affects stability of mycobacterial mRNA , 1996, Journal of clinical microbiology.

[5]  H. Yeager,et al.  Quantitative studies of mycobacterial populations in sputum and saliva. , 1967, The American review of respiratory disease.

[6]  J. T. Crawford,et al.  IS6110, an IS-like element of Mycobacterium tuberculosis complex , 1990, Nucleic Acids Res..

[7]  M. Wootton,et al.  The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[8]  R. Abramson,et al.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Heid,et al.  A novel method for real time quantitative RT-PCR. , 1996, Genome research.

[10]  S. Chanteau,et al.  Follow-up of tuberculosis patients undergoing standard anti-tuberculosis chemotherapy by using a polymerase chain reaction. , 1994, Research in microbiology.

[11]  K. Yuen,et al.  Monitoring the therapy of pulmonary tuberculosis by nested polymerase chain reaction assay. , 1997, The Journal of infection.

[12]  M. V. Doyle,et al.  Quantitation of mRNA by the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Ferré,et al.  Quantitative or semi-quantitative PCR: reality versus myth. , 1992, PCR methods and applications.

[14]  D. Soll,et al.  Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis , 1991, Journal of clinical microbiology.

[15]  S. Gillespie,et al.  Specificity of IS6110-based amplification assays for Mycobacterium tuberculosis complex , 1997, Journal of clinical microbiology.

[16]  D. Moore,et al.  Amplification of rRNA for assessment of treatment response of pulmonary tuberculosis patients during antimicrobial therapy , 1996, Journal of clinical microbiology.

[17]  S. J. Clark,et al.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.

[18]  D. Mitchison,et al.  A selective oleic acid albumin agar medium for tubercle bacilli. , 1972, Journal of medical microbiology.

[19]  W. Stead,et al.  Strand displacement amplification and the polymerase chain reaction for monitoring response to treatment in patients with pulmonary tuberculosis. , 1996, The Journal of infectious diseases.

[20]  D. F. Rochester,et al.  Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment. , 1984, The American review of respiratory disease.

[21]  M. Pfaller.  Application of new technology to the detection, identification, and antimicrobial susceptibility testing of mycobacteria. , 1994, American journal of clinical pathology.

[22]  S. Perrin,et al.  Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Lifson,et al.  Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. , 1993, BioTechniques.

[24]  L. Raeymaekers,et al.  Quantitative PCR: theoretical considerations with practical implications. , 1993, Analytical biochemistry.

[25]  D. Scadden,et al.  Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction. , 1992, The Journal of infectious diseases.

[26]  J. Bates,et al.  Specificity of IS6110-based amplification assays for Mycobacterium tuberculosis complex , 1996, Journal of clinical microbiology.

[27]  E. Palenque,et al.  Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis. , 1995, The Journal of infectious diseases.

[28]  H. Dockrell,et al.  Use of polymerase chain reaction to assess efficacy of leprosy chemotherapy , 1993, The Lancet.

[29]  P. Forgez,et al.  Quantitative RT-PCR: limits and accuracy. , 1996, BioTechniques.

[30]  J. T. Crawford,et al.  Detection of Mycobacterium tuberculosis in sputum samples using a polymerase chain reaction. , 1991, The American review of respiratory disease.